Picture of Parnell Pharmaceuticals Holdings logo

PARNF — Parnell Pharmaceuticals Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Parnell Pharmaceuticals announces financial results for the six-month period ended June 30

Aug 11 (Reuters) - Parnell Pharmaceuticals Holdings Ltd  PARN.O : 
 * Announces financial results for the six-month period ended June 30, 2015 
 * Sales of reproductive hormones in the US are expected to maintain strong 
   growth in the second half of 2015 compared to 2014 
 * Says expect to file the full registration dossiers for zydax for use in dogs, 
   in the US and EU in 2015 
 * Says net loss per weighted-average share was $0.22 for the six-months ended 
   June 30, 2015 
 * All figures in aud$ 
 
 * Source text for Eikon  ID:nGNXVEFAPa  
 
 * Further company coverage  PARN.O   
  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Parnell Pharmaceuticals Holdings

See all news